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Abstract
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Beam tracking with scanned carbon ion radiotherapy achieves highly conformal target dose by
steering carbon pencil beams to follow moving tumors using real-time magnetic deflection and
range modulation. The purpose of this study was to evaluate the robustness of target dose
coverage from beam tracking in light of positional uncertainties of moving targets and beams. To
accomplish this, we simulated beam tracking for moving targets in both water phantoms and a
sample of lung cancer patients using a research treatment planning system. We modeled various
deviations from perfect tracking that could arise due to uncertainty in organ motion and limited
precision of a scanned ion beam tracking system. We also investigated the effects of
interfractional changes in organ motion on target dose coverage by simulating a complete course
of treatment using serial (weekly) 4DCTs from 6 lung cancer patients. For perfect tracking of
̄ was 94.8% for phantoms and
moving targets, we found that target dose coverage was high (V95
94.3% for lung cancer patients, respectively) but sensitive to changes in the phase of respiration at
the start of treatment and to the respiratory period. Phase delays in tracking the moving targets led
to large degradation of target dose coverage (up to 22% drop for a 15 degree delay). Sensitivity to
technical uncertainties in beam tracking delivery was minimal for a lung cancer case. However,
interfractional changes in anatomy and organ motion led to large decreases in target dose coverage
(target coverage dropped approximately 8% due to anatomy and motion changes after 1 week).
Our findings provide a better understand of the importance of each of these uncertainties for beam
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tracking with scanned carbon ion therapy and can be used to inform the design of future scanned
ion beam tracking systems.
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1. Introduction
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Actively scanned carbon ion beams have been used to safely treat a number of static tumors
such as chordomas, chondrosarcomas, and osteosarcomas of the skull base, spine, and
sacrum as well as adenoid cystic carcinomas of the salivary glands (Kraft, 2000; SchulzErtner et al., 2004; Schulz-Ertner and Tsujii, 2007). Given the relatively high tumor control
rates and low toxicity observed for some of those patients (Schulz-Ertner et al., 2007), there
are ongoing efforts to utilize the scanned carbon ion beam for new cancer sites, for example,
gliomas and meningiomas (Rieken et al., 2012), pancreatic cancer (Combs et al., 2013), and
hepatocellular carcinoma (Habermehl et al., 2013; Richter et al., 2014). Indeed, some of
these sites have already been treated successfully with passively scattered carbon ion beams
(Tsujii and Kamada, 2012). However, one of the obstacles to using scanned ion therapy is
that the dose distributions in moving tissue may be highly sensitive to errors and
uncertainties in treatment planning and treatment delivery. Simulation studies investigated
the theoretical dosimetric advantages of using scanned carbon ion beam tracking for moving
tumors, when treatment was delivered perfectly, i.e., with no errors (Bert and Rietzel, 2007;
Lüchtenborg, 2011). Recently, Eley et al. (2014) demonstrated that 4D optimization could
be used with scanned ion beam tracking to further improve target dose uniformity and
reduce dose to avoidance regions near a moving target. In this work, we investigate the
robustness of scanned carbon ion beam tracking in order to understand whether its
theoretical benefits can persist in the presence of uncertainties in patient motion, also
considering the limited precision of a scanned carbon ion beam tracking system.

Author Manuscript

Several investigators have studied the robustness of scanned ion therapy to uncertainties in
treatment planning, treatment delivery, and patient alignment (Pflugfelder et al., 2007;
Lomax, 2008a, b; Meyer et al., 2010). For example, if the patient is misaligned or exhibits a
change in anatomy during a course of therapy, ion Bragg peaks may miss their planned
target position, leading to potential underdosage of the target or overdose to critical
structures outside of the target. If the target is moving, interplay effects between the target
and a moving (scanning) beam (Lambert et al., 2005; Bert et al., 2008) can exacerbate this
problem, potentially leading to treatment failure if adequate motion mitigation strategies are
not used (Bert and Durante, 2011).
As reported by Bert et al. (2007), scanned carbon ion beam tracking relies on real-time
motion state detection to apply tracking offsets to each scanned pencil beam coordinate for
each motion state. In this way, beams are steered to follow motion of the target for all phases
of respiration. In their particular approach, beam-tracking offsets are computed prior to
treatment using a planning 4DCT. Deformable image registration vectors are calculated
from this 4DCT to map the motion of tissues throughout the respiratory cycle, and these
Phys Med Biol. Author manuscript; available in PMC 2016 February 21.
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vector maps are used to compute tracking offsets required for each pencil beam for each
phase of respiration. Similar to beam gating, this approach relies on the assumptions that the
planning 4DCT adequately represents the internal motion of the patient’s organs during
treatment delivery and that a correlation between the patient respiratory phase and the
position of internal organs is reliable for the duration of treatment.
It is not yet known how robust scanned carbon tracking is against violations of these
assumptions. For example, van de Water et al. (2009) studied beam tracking with scanned
proton beams and reported deterioration of target dose coverage when simulated time delays
or position errors were introduced to tracking simulations, which was improved by
combining the principles of rescanning and beam tracking. To our knowledge, the
robustness of target dose coverage to uncertainties in scanned carbon ion beam tracking
therapy for moving tumors has not been reported in the literature.
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The purpose of this study was to evaluate the robustness of target dose coverage to motion
uncertainties for scanned carbon ion beam tracking therapy of moving targets. To
accomplish this, we simulated scanned carbon ion beam tracking for moving targets in both
water phantoms and a sample of lung cancer patients using a research treatment planning
system for ion radiotherapy. We modeled various deviations from perfect tracking that could
arise due to uncertainty in organ motion and limited precision of a scanned ion beam
tracking system in operation at GSI Helmholtzzentrum für Schwerionenforschung GmbH
(GSI) (Darmstadt, Germany). We calculated 4D dose to moving targets for many
combinations of these modeled uncertainties. We also investigated the effects of
interfractional changes in organ motion on target dose coverage by simulating treatment
using multi-week 4DCT images from 6 lung cancer patients. This study seeks to quantify the
reliability, efficacy, and safety of scanned carbon ion beam tracking, which might one day
be used to deliver scanned ion therapy to patients with thoracic tumors.

2. Methods
2.1. Influence of Errors in Beam Tracking on Target Dose Coverage for Phantoms

Author Manuscript

We designed 4 mathematical phantoms with increasing degrees of complexity to evaluate
scanned carbon ion beam tracking. The phantoms are shown in Figure 1. Phantoms 1 and 2
were inspired by patients with liver cancer, i.e., a moving tumor in relatively homogeneous
tissue, and Phantoms 3 and 4 were inspired by patients with lung cancer, i.e., a moving
tumor in heterogeneous tissue. All phantoms were 10 × 10 × 10 cm3, consisting of cubic
voxels with dimension 1 × 1 × 1 mm3. In all phantoms, a 3-cm diameter spherical target
oscillated with sinusoidal motion, with displacement s as a function of time t expressed as s
= A sin4(πt/τ) (Lujan et al., 1999). We studied respiratory periods τ of 3, 4, and 5 s. In
Phantom 1, the sphere oscillated along the x-axis, perpendicular to the beam axis (z), in a
homogeneous water box with amplitude (A) of Ax = 2 cm, i.e., no depth changes. In
Phantom 2, the sphere moved in 3 dimensions, again in a homogeneous water box, with Ax =
2 cm, Ay = 0.5 cm, and Az = 1 cm, with depth changes up to 1 cm along the z-axis. In
Phantom 3, the target moved along the x-axis in water as in Phantom 1, but a simulated rib
heterogeneity was positioned upstream of the target in water to introduce changes in
radiological depths of the target voxels. The rib was approximated as a cylinder with 1-cm
Phys Med Biol. Author manuscript; available in PMC 2016 February 21.
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diameter, inferred from anatomical cross-section measurements of human ribs reported by
Mohr et al. (2007), and 10-cm length parallel to the y-axis with uniform Hounsfield value of
750 (Schneider et al., 2000). In Phantom 4, the rib heterogeneity of Phantom 3 was replaced
by an air cavity with identical dimensions to the rib cylinder, but with uniform Hounsfield
value of −1000. For each phantom, we generated target contours, 4DCT data, and image
registration vector maps to use in treatment planning, corresponding to their unique
geometry and motion characteristics.
Treatment planning and 4D dose calculation for scanned carbon ion beam tracking was
performed using the TRiP4D research treatment planning system (TPS) code (Richter et al.,
2013) as follows.

Author Manuscript
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1.

3DCT images and 3D target contours for a reference motion state were loaded into
the TPS.

2.

A 3D scanned treatment field was planned to irradiate the target in the reference
motion state. A focal spot size of approximately 6.5 mm, full-width at halfmaximum (FWHM), was planned for each pencil beam. In our study, the focal spot
size was defined as the lateral beam width in air of a single pencil beam at the
isocenter of the treatment room, i.e., at the origin of the beam coordinate system.
Pencil beam Bragg peaks were regularly spaced on a 2-mm Cartesian grid within
each isoenergy layer. Pencil beam energies were selected to provide a 3-mm waterequivalent depth spacing between isoenergy layers, and a 3-mm ripple filter
(Weber and Kraft, 1999) was used to blur the carbon Bragg peaks in the depth
direction. A radial target margin of 1.1 × FWHM, i.e., perpendicular to the beam
central axis, was used to ensure sufficient lateral-scatter-equilibrium to achieve
target dose coverage at the off-axis target boundary. A distal target margin of 4-mm
water-equivalent thickness was used to achieve target dose coverage at the distal
target boundary.

3.

The numbers of carbon ions in each beam spot were optimized to achieve uniform
relative-biological-effectiveness- (RBE) weighted dose to the target for the 3D
static case in the reference motion state. An RBE value of 1 was used for phantom
studies.

4.

4DCT images and 4D image registration vectors were loaded into the TPS.

5.

Following the methods of Bert and Rietzel (2007), beam tracking offsets were
calculated for each pencil beam for each motion state so that each pencil beam
Bragg peak would arrive at its planned local anatomic subvolume of the target
regardless of the motion state presented during irradiation (see Figure 2). Lateral
tracking offsets, i.e., x- and y-offsets orthogonal to the beam central axis, were
calculated by projecting 4D image registration vectors onto an xy-plane
perpendicular to the beam central axis (z). Range-tracking offsets, i.e., z-offsets,
were calculated to compensate changes in the radiological depth of the target at
points coinciding with the Bragg peak position for each pencil beam. First, 4D
image-registration vectors were used to map the movement of a subvolume in the
target (e.g., a single voxel containing a pencil beam Bragg peak) from its position
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in the reference motion state to its position for all other motion states. Second, the
radiological depth of that (moving) subvolume was calculated uniquely for each
motion state using an existing ray-tracing algorithm in TRiP4D and using the
appropriate 3DCT subset of the 4DCT. Finally, a range-tracking offset was
calculated based on the change in radiological depth of the subvolume (containing
the Bragg peak coordinate) for all motion states.
Idealized patient respiratory motion trace signals, i.e., with constant respiratory
period, were loaded into the TPS. These motion signals were used to simulate those
that would be monitored in real-time during treatment delivery, for example using a
respirometer.

7.

Beam-tracking 4D delivery was simulated. Based on the patient respiratory motion
trace signal (e.g., period and starting phase), the required particles per pencil beam,
and the availability of particles from the accelerator spill sequence (characteristic of
the current GSI synchrotron), temporal characteristics of 4D delivery were
simulated by binning each pencil beam into the motion state in which it would most
likely be irradiated (Richter et al., 2013). The corresponding tracking offsets (from
Step 5) were added to each pencil beam Bragg peak coordinate depending on the
motion state into which it was binned. Using new TPS codes developed in this
work, errors were added to the x, y, and z components of each tracking offset to
simulate the effect of motion uncertainties, described in further detail below.

8.

Finally, 4D RBE-weighted dose was calculated by accumulating dose to voxels
from all pencil beams for all discrete motion states (Richter et al., 2013).
Coordinates of the target voxels were transformed for each motion state using the
deformable image registration vectors to allow summation of 4D dose to the
moving voxels.

Author Manuscript

6.

Author Manuscript

For perfect tracking, we simulated 18 motion scenarios for each phantom with variation in
motion trace signals with period, τ = 3, 4, and 5 s, and starting respiratory phase at
beginning of irradiation, ϕ = 0, 60, 120, 180, 240, and 300 degrees. Our rationale for these
multiple motion scenarios was that, even when pencil beams perfectly track target motion
and depth changes, some deviations in off-axis dose contributions for individual pencil
beams are expected (van de Water et al., 2009). By sampling these 18 scenarios of motion,
we avoided the chance that our findings would be confounded by a single “lucky” or
“unlucky” choice of τ or ϕ.

Author Manuscript

We modeled both systematic and random positional uncertainties as well as temporal lags
during beam tracking therapy. Ultimately, uncertainties were simulated by shifting pencil
beam coordinates and modifying target motion signals prior to 4D dose calculation as
illustrated in Figure 2. For each individual uncertainty modeled, we also included 18 motion
scenarios of respiration with variable period and starting phase as described for the perfect
tracking case above. A list of modeled uncertainties and a brief description of our rationale
and implementation in our TPS is given below.

Phys Med Biol. Author manuscript; available in PMC 2016 February 21.
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A. Phase Delays in Beam Tracking
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•

Rationale: Delays in applying tracking offset to individual pencil beams for given
motion states might be caused either by delays in the motion state detection system
or by delays in the beam tracking control system or beam delivery system.

•

Implementation: Delays were simulated by loading both an internal motion signal
(i.e., representing the “true” tumor motion) and an external motion signal (e.g., that
could represent motion of an external surrogate marker) into the TPS (Richter et
al., 2013). The internal motion signal was used to synchronize the temporal
delivery of pencil beams to their appropriate 4DCT motion state for 4D dose
calculation (see Step 7 above), but the external motion signal was used to
determine a given beam-tracking offset. By delaying the external motion signal, we
caused tracking offsets to be applied from an incorrect motion state, depending on
the amount of delay.

•

Variables Simulated: Phase delays of 0, 5, 10, and 15 degrees were simulated.

B. Random Errors in Bragg Peak Coordinates

Author Manuscript

•

Rationale: Random errors in Bragg peak coordinates during beam tracking might
be caused by limited precision of the beam tracking system, i.e., scanner magnets
and range-tracking wedge.

•

Implementation: Random errors were sampled from Gaussian distribution with a
user specified width (σ) using a random number generator and added to beamtracking offsets prior to 4D dose calculation.

•

Variables Simulated: We applied 1D random errors independently to x, y, and z
with σ of 0, 0.5, 1.0, and 1.5 mm. We also applied combined 3D random errors to
x, y, and z with σ values of 0, 0.5, 1.0, and 1.5 mm.

C. Systematic Errors in Bragg Peak Coordinates

Author Manuscript

•

Rationale: Systematic errors in Bragg peak coordinates during beam tracking
therapy might be caused by misalignment of the patient, patient shifting after setup,
or by weight change of the patient.

•

Implementation: Systematic errors were added to pencil-beam tracking offsets prior
to 4D dose calculation.

•

Variables Simulated: We applied 1D errors of 0, 1, 2, 3, and 4 mm independently
to x, y, and z pencil beam coordinates. We also applied combined 3D errors of 0, 1,
2, 3, and 4 mm simultaneously to x, y, and z pencil beam coordinates.

D. Limited Acceleration of Range-tracking Wedge System
•

Rationale: When a motion state change occurs or a new pencil beam begins
irradiation, a new range-tracking offset must be applied. The tracking system at
GSI uses a passive acrylic wedge system mounted on linear drive motors that move
material in or out of the beam path. This motorized system has a finite acceleration

Phys Med Biol. Author manuscript; available in PMC 2016 February 21.
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of 8 g (1 g = 9.81 m/s2), i.e., in water-equivalent range changes, (Saito et al., 2009)
that delays immediate application of the range-tracking offset.

Author Manuscript

•

Implementation: We implemented equations for 1D motion of the range-tracking
wedge pair under the influence of constant acceleration, constant deceleration, or
no acceleration into our TPS. When a new tracking range-offset was requested
during treatment simulation, e.g., when a new pencil beam started irradiation or a
motion state change occurred, we considered the current position and velocity of
the range-tracking wedge and simulated its trajectory that would allow it to most
quickly reach and stop at the desired new position. From this trajectory we
determined the mean wedge-position for each pencil beam for each motion state
and used that mean position as the range-tracking offset for our simulations.

•

Variables Simulated: We simulated range-tracking wedge acceleration values of
0.001, 0.01, 0.1, 1, 8, 10, and 100 g and a hypothetical wedge with infinite
acceleration. The infinite acceleration wedge was used for our reference case
simulations. These acceleration values correspond to acceleration of beam range
along the beam central axis (z), i.e., in terms of changing water-equivalent
thickness of the acrylic wedge in the beam path.

Author Manuscript

All 4D dose distributions were transformed to a reference 3D motion state for analysis. For
each phantom and each variable studied, we combined the target dose distributions for the
18 scenarios of possible respiratory patterns. From these combined distributions, we
prepared box-whisker plots to allow easy visualization of the entire distribution of target
dose expected for a single modeled uncertainty. We also determined the volume of the target
receiving at least 95% of the prescribed dose (V95), the volume of target receiving greater
than 107% of the prescribed dose (V107), and D5-D95, the difference between the highest
dose in the target, after excluding 5% of the target volume receiving the very highest dose,
and the lowest dose in the target, after excluding 5% of the target volume receiving the very
lowest dose. V95 was used to quantify target dose coverage, V107 was used to quantify target
overdosage, and D5-D95 was used to quantify target dose homogeneity. For select cases, we
plotted 2D cuts from the dose distributions as colorwash overlaying the phantom and target
contours.
2.2. Influence of Errors in Beam Tracking on Target Dose Coverage for Lung Treatment

Author Manuscript

We simulated the impact of motion uncertainties on target dose coverage for one lung
patient (Lung Patient #1), who was previously enrolled in a research study at The University
of Texas MD Anderson Cancer Center (UTMDACC) (Houston, TX) and who had a peak-topeak tumor motion amplitude of 25 mm. For this lung cancer patient, treatment planning for
scanned carbon beam tracking was similar to that described for the water phantoms in
Section 2.1, with the following differences. Instead of 1 field, we used the 4-field irradiation
protocol developed at NIRS for hypofractionated lung cancer therapy with carbon beams
(Miyamoto et al., 2007). We used gantry angles of +20, −20, −70, and −110 degrees that
corresponded to the angles used at NIRS. For reference, in TRiP4D, 0 degrees represents a
lateral beam and −90 degrees represents an AP beam. The couch angle was −90 degrees,
hence all beams fell in an axial plane. We used the Local Effect Model Version IV at GSI
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(Scholz et al., 1997; Elsässer et al., 2010) along with TRiP4D to optimize and calculate
RBE-weighted carbon dose distributions, i.e., for the biological endpoint of lung tumor
control. For this, we used an α/β ratio of 6 Gy for lung tumor control (α = 0.021 Gy−1, β =
0.0035 Gy−2, DT = 10 Gy) (Lüchtenborg, 2011). We planned 8.2 Gy (RBE) for each of the 4
fields for a total RBE-weighted dose of 32.8 Gy (RBE) to the target. We used a combination
of both rigid image registration vectors and deformable image registration vectors to plan
beam-tracking offsets and to calculate 4D accumulated dose, respectively. Lüchtenborg et
al. (2011) demonstrated that keeping a rigid spacing between neighboring pencil beams can
provide a more homogeneous target dose for beam tracking, since a deforming grid can lead
to bunching and dispersion of pencil beams that causes local overdosing and underdosing
within the target, respectively. Thus, we used rigid vectors to plan beam-tracking offsets, but
we used deformable image registration vectors in the 4D dose calculations. For calculation
of rigid image registration vectors, we only considered motion of tissue within the CTV
boundary. For calculation of deformable image registration vectors, we used the entire
4DCT data set.
For Lung Patient #1, motion uncertainties and beam tracking uncertainties were simulated
identical to those described for the water phantom studies in Section 2.1. Analysis of target
dose distributions was similar to that described for the water phantoms. In all cases, the 4D
RBE-weighted dose distributions from the combined 4 fields were transformed to a 3D
reference motion state at end-exhale for analysis. In addition, we also plotted the full
distribution of beam tracking offsets required for each pencil beam and each motion state.
2.3. Influence of Interfractional Changes in Organ Motion on Target Dose Coverage for
Lung Treatment

Author Manuscript
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One serious criticism of scanned ion beam tracking is that the approach currently assumes
true periodic organ motion and that there exists a perfect correlation between the patient
respiratory phase and the motion of internal anatomy. For example, if only external motion
surrogates, such as markers fixed to the sternum, were monitored during treatment delivery,
an uncorrelated or poorly correlated internal motion deviation might not be detected. If drifts
in absolute tissue position would occur, e.g., due to muscle relaxation over the course of
several minutes, then respiratory phase alone may not accurately be used to predict the
position of internal organs. In addition, weight changes of the patient during a course of
treatment likely leads to changes in the range of ion pencil beams in tissue. Therefore, we
sought to better understand the dosimetric consequences of relying on these assumptions by
simulating scanned carbon ion beam tracking therapy using an initial 4DCT for treatment
planning and then using a multiple-week series of 4DCT images, acquired for the same set
of patients, to simulate treatment and delivery of 4D dose distributions to the patients at later
time points.
To study the effects of interfractional changes in organ motion on target dose coverage for
scanned carbon beam tracking, we selected 6 lung cancer patients who were previously
enrolled in a research study at UTMDACC and had undergone multi-week serial 4DCT
imaging. These patients received a 4DCT imaging sequence each week following the
methods of (Pan et al., 2004), with images binned into 10 phases of their respiratory cycle.
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Our approach was to prepare a scanned carbon ion beam tracking treatment plan using the
first 4DCT image set and, then, to simulate treatment delivery without any subsequent
adaptation using the later 4DCT image sets.
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We used the software program Plastimatch using B-splines (Shackleford et al., 2010) to
calculate deformable image registration vectors for each patient for each 4DCT image series
to use in 4D dose calculation. We calculated rigid image registration vectors for all phases
of the first 4DCT set to plan beam tracking offsets as described in Section 2.2. In addition,
we rigidly registered the patient position at a reference state of end-exhale throughout all
weeks of 4DCT images. From this, we rigidly offset the CT voxel coordinates when
simulating treatment on later week 4DCTs. This concept is similar to aligning the patient
before each treatment, e.g., using an onboard imaging device such as orthogonal x-ray
planar images or cone-beam CT images. Treatment plans were prepared as described in
Sections 2.1 and 2.2, again using 4 fields and 32.8 Gy (RBE) total dose. For patients with
targets in the right lung, the couch angle was changed from −90 to 90 degrees. For
calculation of dose on later 4DCTs, the correct 4DCT and corresponding deformable image
registration vector map was loaded into the TPS just before calculating 4D dose. For 6
patients, we calculated dose on 3 4DCTs, i.e., week 0, 1, and 2. For Lung Patient #1, we also
used a second 4DCT scan from week 0 to investigate interfractional motion changes that
might occur during a single day, however, this data was not available for the other 5 patients
in our study. For each treatment simulation, we used 18 different respiratory motion signals
with variable period and starting phase as described in Section 2.1.

Author Manuscript

Analysis of target dose distributions was similar to that described for the water phantoms. In
all cases, the 4D dose distributions from the combined 4 fields were transformed to a 3D
reference motion state at end-exhale for analysis.

3. Results

Author Manuscript

Robustness of target dose coverage for scanned carbon ion beam tracking was found to be
sensitive to errors in beam tracking. The major qualitative findings are as follows. As
expected, robustness was generally poorer when heterogeneities were present near the target.
However, robustness was generally better for patient plans, where we used 4 equal-weight
beams, compared to the mathematical phantom plans with simulated heterogeneities, where
we used only a single beam. Overall, coverage was found to be most sensitive to phase
delays in beam tracking, systematic spatial errors in tracking, and interfractional changes in
organ motion. Limited acceleration of the range-tracking wedge was found to have a
moderate impact on target dose coverage, particularly for the lung patient. Random errors in
beam tracking arising from the limited precision of beam steering magnets and the precision
of the range-tracking wedge system were found to have minimal impact on target dose
coverage.
In the following sections, we detail our quantitative findings for the robustness of scanned
carbon ion beam tracking for each modeled error. First, we present dose-colorwash plots to
illustrate our treatment plans for perfect tracking scenarios. Then, we present dose-volume
statistics for the moving targets for all cases of simulated errors in beam tracking. We also

Phys Med Biol. Author manuscript; available in PMC 2016 February 21.

Eley et al.

Page 10

Author Manuscript

present tables to summarize the robustness of V95, our main metric for target coverage, as a
function of the simulated errors in beam tracking. Finally, we present the robustness of
target dose coverage to interfractional changes in organ motion for 6 lung cancer patients.
3.1. Influence of Errors in Beam Tracking on Target Dose Coverage for Phantoms

Author Manuscript

For our simulations of perfect beam tracking (for the motion scenario with τ = 4 s and ϕ = 0
degrees), we found a highly uniform and nearly identical target dose for Phantoms #1 and #2
with mean target doses of 100 ± 1 %, i.e., percent of the prescribed target dose, for both
phantoms. However, we found slightly less-uniform target dose for Phantoms #3 and #4,
which both had a cylindrical heterogeneity upstream of the moving target, with mean target
doses of 100 ± 3 % and 99 ± 5 %, respectively. Dose distributions are shown as 2D
colorwash cuts in the XZ plane in Figure 3 for perfect tracking. Dose-volume statistics for
perfect tracking are shown in Figure 4, at points where the phase delay was 0 degrees (i.e.,
no delay). We observed that the target dose coverage for perfect tracking for Phantoms #1
and #2 was not affected by respiratory period or starting phase, and all 18 data points (for
the 18 scenarios of respiratory motion with variable period (τ) and starting phase (ϕ))
overlay exactly. However, for Phantoms #3 and #4, we observed differences in target dose
coverage for those 18 scenarios depending on the respiratory period and respiratory starting
phase. Thus, even for perfect tracking, target dose coverage was found to be degraded by
heterogeneous tissue upstream of the moving target.
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The robustness of target dose coverage to simulated phase delays in beam tracking is shown
in Figure 4. A rapid degradation of target dose coverage (V95) with increasing phase delay is
seen for all 4 phantoms. For an example, if the respiratory period were 4 s, these phase
delays of 5, 10, and 15 degrees would correspond to temporal delays of 56, 111, and 167 ms,
respectively. Such phase delays in beam tracking could potentially arise from lags in realtime detection of a patient’s current motion state or lags in real-time application of tracking
offsets with the beam delivery system. Future countermeasures against these delays could
include increasing the processing speed in motion-state-detection electronics and possibly
implementing predictive algorithms.

Author Manuscript

The impact of random spatial errors in beam tracking on target dose coverage was found to
be minimal (V95 changed less than 1%) when errors were sampled from Gaussian
distributions with σ ≤ 0.5 mm. Furthermore, only slight degradation of target dose coverage
was seen with random errors sampled with σ values up to 1.5 mm (cf. Table 1). For
reference, the precision in lateral x and y pencil beam spot position for beam tracking, as
determined by the dipole scanning magnets and position feedback system, is approximately
0.16 mm for the GSI carbon ion synchrotron including positional feedback loop, and the
precision in the z range-tracking offsets, determined by the water-equivalent pathlength
through the range-tracking wedge system, is approximately 0.25 mm (Saito et al., 2009).
Thus, we infer that the precision of the current beam delivery system at GSI is already
slightly better than needed and that further efforts to improve spatial precision in beam
delivery will likely not improve robustness for beam tracking.
Target dose coverage was found to be highly sensitive to systematic spatial errors in beam
tracking. Errors up to 4 mm led to an approximately 21% drop in target coverage V95,
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averaged over all phantoms. Figure 5 shows the robustness of target dose coverage to
combined systematic errors in tracking x-, y-, and z-coordinates. For Phantoms #1 and #2,
minimal effect on target dose was seen until the errors were greater than 2 mm, with visible
drops in coverage at errors of 3 and 4 mm, likely caused when the scanned ion field edge
moves very close to the target boundary. In contrast, for Phantoms #3 and #4, loss of target
dose coverage was seen even for 1 mm systematic spatial errors and increased with the
amount of error. This effect was dominated by lateral (x-axis) errors in tracking (cf. Table
1), since relatively small lateral shifts introduced comparably large changes in radiological
depth of the target due to the cylindrical heterogeneities present upstream of the target for
Phantoms #3 and #4. Therefore, the robustness of beam tracking to systematic spatial errors
was poorer when heterogeneities were present.

Author Manuscript

For the 4 phantoms, we found target dose coverage to be mostly insensitive to wedge
acceleration for a ≥ 8 g (1 g = 9.81 m/s2). However, for acceleration less than 1 g, target
dose coverage deteriorated with decreasing acceleration. Note that the direction of
acceleration is reported not in the direction of wedge motion but rather in the beam
direction, i.e., quantifying the change in water-equivalent pathlength through the acrylic
wedge. Figure 6 shows the robustness of target dose coverage when we simulated variable
acceleration of the range-tracking wedge system. Our reference case of perfect tracking was
modeled with infinite wedge acceleration. To put these numbers in perspective, the range
tracking wedge system implemented at GSI can modify the beam range with an acceleration
of approximately 8 g (Saito et al., 2009).
3.2. Influence of Errors in Beam Tracking on Target Dose Coverage for Lung Treatment

Author Manuscript

The robustness of target dose coverage to tracking errors in patient cases can be better
understood by looking at an exemplary distribution of tracking parameters needed for a lung
tumor moving in heterogeneous tissue. Figure 7 shows the distribution of beam tracking
offsets required for Lung Patient #1 for Field #1 (gantry angle of −20 degrees) for all pencil
beams and all motion states for perfect tracking. The x tracking offsets compensated SI
motion of up to approximately 25 mm, while y tracking offsets compensated mainly AP
motion up to approximately 5 mm. The z offsets compensated changes in radiological depth
of the target tissue, requiring up to 25 mm of range-compensation in some motion states,
with large variations in range tracking needed for different pencil beams within single
motion states. These large fluctuations in range-tracking offset values put high technical
demands on the treatment delivery system for patient cases, e.g., when a tumor moves in
heterogeneous lung tissue, and are a concerning factor for tracking robustness.

Author Manuscript

Our treatment plan for Lung Patient #1 is shown in Figure 8(a) with a 2D cut of 4D RBEweighted dose overlaying a CT image in the reference motion state at end-exhale for perfect
beam tracking (τ = 4 s and ϕ = 0 degrees). We observed a uniform target dose coverage of
32.7 ± 1.1 Gy (RBE) with a rapid falloff of dose outside the target volume. Dose-volume
statistics for perfect tracking (for all 18 scenarios of variable respiratory period and starting
phase) are shown in Figure 9, at points where the offset is 0.0 (i.e., no offset). Similar to
Phantom #3 with the rib heterogeneity, some dependence of target dose coverage on
respiratory period and starting phase is seen even for perfect tracking, though not as much as
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that seen for Phantom #4 with the air heterogeneity. These 18 dose distributions provide our
baseline estimate of target dose coverage (V̄95 = 95.5%) for perfect beam tracking for Lung
Patient #1, against which we compare our dose distributions with simulated errors in
tracking, discussed in the remainder of this section and summarized in Table 2.
Target dose coverage was found to be highly sensitive to phase delays in beam tracking.
Phase delays up to 15 degrees led to drops in target dose coverage (V̄95) up to 18%. These
findings were similar to and confirm those of our phantom study (cf. Figure 4). Thus, phase
delays in tracking were a major detriment to target dose coverage for beam tracking for both
phantom and patient cases.

Author Manuscript

The impact of random spatial errors in beam tracking on target dose coverage for Lung
Patient #1 was found to be minimal (V̄95 changed less than 1%) when errors were sampled
from Gaussian distributions with σ ≤ 1 mm (cf. Table 2). Compared with the phantoms, even
less effect was seen in Lung Patient #1, likely due to averaging effects for the 4 beams. As
discussed in Section 3.1, the precision in beam tracking is better than 0.3 mm for the
experimental system at GSI. We determined that random spatial errors in beam tracking had
negligible impact on target dose coverage for the precision of our tracking system.

Author Manuscript

Target dose coverage was found to be highly sensitive to systematic spatial errors in beam
tracking. Errors up to 4 mm led to an approximately 16% drop in target coverage V95,
averaged over all phantoms. Figure 9 shows the robustness of target dose coverage to
combined systematic errors in tracking x-, y-, and z-coordinates. Only minimal effect on
target dose (< 3% change in V̄95) were seen until the errors were greater than 2 mm, with
larger drops in target dose coverage and slight loss of dose homogeneity for errors of 3 and 4
mm, as the scanned ion field edge approaches the target boundary. The drop in target
coverage V95 due to systematic errors for Lung Patient #1 was less dramatic than for either
of the phantoms with heterogeneities (cf. Figure 5), likely explained by blurring out of dose
errors by the 4 fields. Overall, the robustness of beam tracking to systematic errors was
better for the patient case compared to the phantoms but still a major concern.
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For Lung Patient #1, target dose coverage was degraded due to limited acceleration of the
range tracking wedge, except for very high wedge acceleration (e.g., a > 100 g). Figure 10
plots the robustness of target dose coverage to limited acceleration of the range-tracking
wedge for the patient. The reference case of perfect tracking was represented by infinite
wedge acceleration. Simulation of 100 g wedge acceleration produced nearly identical target
dose coverage to that with infinite wedge acceleration. For wedge acceleration of 1 to 10 g,
similar target dose coverage V95 is seen approximately 5% lower than that seen for perfect
tracking (cf. Table 2). At wedge accelerations below 1 g, target dose coverage deteriorates
even further with decreasing wedge acceleration. The range-tracking wedge system
implemented for experiments at GSI has an acceleration of approximately 8 g and, thus,
might not achieve the dose coverage needed for patients.
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3.3. Influence of Interfractional Changes in Organ Motion on Target Dose Coverage for
Lung Treatment

Author Manuscript

Target dose coverage was found to deteriorate greatly due to interfractional changes in organ
motion 1 and 2 weeks post-planning, as studied for 6 lung cancer patients using multi-week
4DCTs. To give an overview of these patients and the variety of lung tumors studied, Figure
8 shows our treatment plans overlaying CT images from the initial planning 4DCT (week 0),
i.e., for perfect tracking (τ = 4 s and ϕ = 0 degrees). Figure 11 shows the robustness of target
dose coverage to interfractional motion changes for the 6 lung patients. The median target
dose remained stable for all patients, within 4% of the prescribed dose, even up to 2 weeks
after planning. However, more importantly, the target dose coverage (V95) deteriorated with
time post-planning. Averaged for all 6 patients (and for the 18 motion scenarios), V̄95
dropped from 94.3% at week 0 to 85.9% and 86.2% for treatment simulated 1 and 2 weeks
after planning, a mean decrease in V̄95 of 8.4% and 8.1%, respectively. Target dose coverage
deteriorated more with time post-planning for Patients #1 and #2, who had the greatest
motion amplitudes (up to 25 mm). Overall, target dose coverage (V95) was significantly
degraded by interfractional changes in organ motion though median target dose was not.
3.4. Summary of Results

Author Manuscript
Author Manuscript

•

For simulations of perfect scanned beam tracking of moving targets in
heterogeneous matter, we found that dose distributions were sensitive to the phase
of respiration at the start of irradiation and to the respiratory period. Even when the
pencil beam Bragg peaks perfectly tracked the moving target, off-axis dose
contributions from individual pencil beams were affected by variation in tissue
upstream of the moving target and dose was degraded. This finding confirms the
finding of van de Water et al. (2009).

•

Phase delays in tracking the moving targets led to large degradation of target dose
coverage. This finding supports the need for predictive algorithms for motion
tracking and fast, i.e., few ms, hardware to apply beam-tracking parameters in real
time during treatment.

•

Random tracking errors sampled from a Gaussian distribution with σ < 0.5 mm had
negligible effect on target dose coverage.

•

Systematic errors in beam tracking, which could be caused by patient
misalignment, baseline drifts in target position, or errors in image registration used
for planning, caused two distinct ill effects on target dose coverage. First, simple
misalignment of the target with the radiation field boundary led to underdosage of
the target, as the target moved near the dose falloff region. This degradation was
observed with errors greater than 2 mm and could likely be addressed simply by
using treatment margins, similar to a PTV concept (margins were purposefully
omitted from this study). Second, a more complex relation was seen in
heterogeneous tissue, and even relatively small, e.g., 1 mm, lateral positional errors
led to degraded dose, likely since the radiological thickness of tissue upstream of
the target can vary greatly off axis. Thus, lateral misalignment of a pencil beam can
manifest as an incorrect depth of its Bragg peak in a complex manner.
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The limited acceleration of the range-tracking wedge led to minimal degradation of
target dose when acceleration was ≥ 8 g for phantoms. We observed an inflection
and rapid worsening of target dose when acceleration was ≤ 1 g. Our patient
simulations suggest that a higher wedge acceleration > 10 g might be required to
improve target dose coverage, but our data do not suggest the need for acceleration
greater than 100 g. If very fast range-tracking is needed in the future, the method of
Chaudhri et al. (2010), which uses magnetic beam deflection and a static wedge
degrader, might be preferable to the mechanically actuated wedge system assumed
in this study.

•

For the 6 lung cancer patients in our study with multi-week 4DCTs, interfractional
changes in organ motion did not lead to large changes in the median target dose,
i.e., median dose was within 4% of that prescribed, even up to 2 weeks after
planning. However, as expected, dose coverage (V95) worsened with time, dropping
approximately 8% after 1 week post-planning. Larger degradation of dose coverage
was observed for patients with greater tumor motion. For Lung Patient #1, V95
dropped approximately 7% due to variation in organ motion occurring during a
single day.

Author Manuscript

•

Author Manuscript

4. Discussion

Author Manuscript

In this study, we evaluated the robustness of target dose coverage to motion uncertainties for
3D-optimized scanned carbon ion beam tracking therapy for moving targets. We
implemented new algorithms in a research TPS to allow simulation of a number of
deviations from perfect tracking. Additionally, we investigated the robustness of beam
tracking to interfractional changes in organ motion using multiweek 4DCTs for a sample of
lung patients. We found target dose coverage for scanned carbon ion beam tracking therapy
to be sensitive to a number of motion uncertainties. Sensitivity was minimal for the lung
cancer case against technical uncertainties of beam delivery. Higher sensitivity was seen
with respect to changes of anatomy as studied in the multiweek analysis. Our findings can
be used to inform the design specifications of future scanned ion beam tracking systems and
to inspire future motion mitigation strategies.

Author Manuscript

One major strength of this work is that this approach gives a view of the motion problem
that cannot be explored using commercial treatment planning systems. By the thousands
(nearly 4000 dose calculations were reported in this work) of 4D dose calculations possible
using a research TPS and a research computing cluster, we were able to isolate motion
uncertainties related to beam tracking and to test the robustness of target dose coverage
independently to these uncertainties. Another strength is that many of these methods are
general and might also be used to simulate the effect of motion uncertainties on dose for
future motion-mitigation strategies for scanned ion therapy, such as breath hold, beam
gating, or rescanning. In this work, we evaluated the robustness of target dose coverage for
moving phantoms and lung patients without using setup or motion margins, i.e., no “PTVtype” margins, which could have masked underlying changes to the desired dose distribution
caused by small errors in beam tracking. This means that our results can be used to
understand the baseline robustness of scanned carbon beam tracking and also be used to
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decide margins and positional precision requirements that best ensure robustness of target
dose coverage for future patient treatments.
Our finding of imperfect target dose coverage even for perfect tracking confirms that
reported by van de Water et al. (2009). However, their study did not include patient
simulations, whereas we found target dose coverage to be more robust to tracking errors in
patient anatomy compared with our mathematical phantoms. These heterogeneous phantoms
could be viewed as a worst-case example since such cylindrical geometries with discrete
edges are rarely found in patients. Since we found target dose coverage to depend on patient
starting phase and respiratory period, even for perfect tracking, we expect that rescanning
with beam tracking, as suggested by van de Water et al. (2009), would likely provide a more
robust dose coverage for targets moving in heterogeneous tissue.

Author Manuscript
Author Manuscript

Our study had several limitations. One limitation was that we only investigated robustness to
technical (i.e., beam delivery system) uncertainties for one lung patient, who had the highest
motion amplitude in our sample of 6 patients. Thus, we might overestimate the sensitivity of
target dose coverage to errors in tracking compared to that possible for patients with less
tumor motion. Another limitation of this work was that we simulated temporal aspects of
beam delivery using a spill-intensity profile typical of the SIS 18 synchrotron at GSI. Thus
some of our findings, mainly those regarding the impact of limited wedge acceleration,
would likely change for accelerators with spill-intensity (temporal) profiles vastly different
from that of the GSI synchrotron. To coarsely understand this, we repeated a small part of
our study using a hypothetical spill-intensity profile, which was identical to our original
profile, but simulated to occur 10 times faster. Those results (cf. Supplementary Data) show
some differences but encourage that the spill intensity profile does not have a large influence
on our major findings. A full analysis of that problem needs to be addressed in future
studies. Another limitation was that we optimized the particle fluence for a single reference
motion state, e.g., at end-exhale, prior to calculating the beam tracking offsets for each
pencil beam for each motion state. That is, we did not account for all motion states in the
planning of particle numbers, which partially explains some of our degraded target dose
coverage seen even for perfect tracking. These limitations are being addressed in ongoing
studies in our laboratory (Eley et al., 2014); however, they did not prevent us from
achieving our objective, which was to evaluate the robustness of target dose coverage to
motion uncertainties for scanned carbon ion beam tracking therapy of moving targets.

Author Manuscript

Based on our findings, we propose the following future studies. First, we suggest that
appropriate beam-specific margins be designed to mitigate range errors introduced by lateral
target misalignment, similar to the approach of Park et al. (2012), but also including motion
margins needed to cover the deforming tissue during respiration (Graeff et al., 2012). To
investigate this, we briefly repeated part of our study using beam-specific, robust (rangeproof) margins and, indeed, found some improvements to the median target coverage for
Patient #1, which appeared to persist for treatment simulated at 1 and 2 weeks after
treatment planning (cf. Supplementary Data). However, this improvement did not exist for
all scenarios of respiratory period and starting phase, which indicates that margins alone will
likely not provide a comprehensive solution due to persisting interplay effect in the target.
Nonetheless, we speculate the ideal field margins could be a “center-of-mass ITV,” which
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covers any range changes (i.e., changes in radiological depth of the target boundary) and
lateral deformations for all motion states, specifically considering the deviations in the
center-of-mass frame and likewise using the center of mass as the beam tracking target
centerpoint. Such a center-of-mass ITV concept could also be used with motion detection
systems that directly determine the tumor location, instead of surrogate detection. Thus,
lateral beam tracking parameters could be determined in real time and would not need to
rely on a planning 4DCT. The remaining issue of range tracking might still be addressed
using vectors derived from a planning 4DCT or, alternatively, range tracking might be
abandoned entirely, which might also achieve acceptable target dose coverage
(Lüchtenborg, 2011), especially when multiple beam angles are used. In addition, based on
the findings of van de Water et al. (2009), we expect that rescanning combined with beam
tracking will offer improved robustness.

Author Manuscript

Strategies to improve robustness have already been developed for both photon therapy
(Bortfeld et al., 2008; Unkelbach et al., 2009) and particle therapy (Unkelbach, 2007;
Pflugfelder et al., 2008; Chen et al., 2012; Liu et al., 2012). Many of these strategies
incorporated uncertainties in plan optimization to improve probability of tumor control in
the presence of patient setup uncertainty, though, to our knowledge, do not yet explicitly
address organ motion for particle therapy. Theoretically, robust 4D optimization could be
used to optimize particle numbers that are both optimal for all motion states and robust to
motion uncertainties, which would be beneficial, since, for this beam tracking approach, it is
unknown prior to treatment in which motion state a pencil beam will be irradiated.

Author Manuscript

In summary, we developed a new method to model the impact of motion uncertainties for
scanned ion beam tracking and implemented our work in a 4D research treatment planning
system. We quantified the sensitivity of target dose to several uncertainties present in
scanned carbon ion beam tracking for moving tumors using both mathematical phantom
studies and retrospective lung cancer patient studies. Our results provide a better
understanding of the importance of each of these uncertainties for beam tracking with
scanned carbon ions.
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Figure 1.
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Schematic drawings of phantoms. In Phantom #1 (a), a 3-cm spherical target (black circle)
moves sinusoidally along the x-axis (Ax = 2 cm) with no change in depth in a uniform water
phantom. In Phantom #2 (b), another such sphere moves sinusoidally in 3D (Ax = 2 cm, Ay =
0.5 cm, Az = 1 cm) with 1-cm change in depth in a uniform water phantom. In Phantoms #3
and #4 (c), another sphere moves sinusoidally along the x-axis (Ax = 2 cm) in a water
phantom, but a heterogeneity (grey shaded area) is modeled upstream of the target as a
cylinder (1-cm diameter, 10-cm length) parallel to the y-axis. For Phantom #3, the cylinder
has uniform Hounsfield value of 750, to approximate a rib. For Phantom #4, the cylinder has
uniform Hounsfield value of −1000, to represent an air cavity.
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Figure 2.
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Diagram of perfect beam tracking and beam tracking with simulated motion uncertainties.
For perfect tracking, a set of ion pencil beams (arrows) are distributed throughout a target
volume (circle) in the reference Motion State 1 (left) with individual Bragg peaks located in
subvolumes of the target (small squares). After the target moves to Motion State 2 (middle),
each pencil beam also moves to track the subvolumes. To simulate the effect of motion
uncertainties, we offset individual pencil beam positions (right). The offset pencil beams
(right) are shown to irradiate new subvolumes (small squares) that partially or fully miss
their planned subvolumes in the target (dashed small squares), usually leading to
deterioration of the planned target dose coverage.
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Figure 3.
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Perfect beam tracking dose distributions in XZ plane shown for a reference scenario (τ = 4 s
and ϕ = 0 degrees) for Phantom #1 (a), Phantom #2 (b), Phantom #3 (c), and Phantom #4
(d). Target indicated by large white circle. Beam direction was −z. For Phantoms #3 and #4,
a proximal slab (z in 80–100 mm) did not move and contained the rib cylinder and air
cylinder heterogeneities, respectively, indicated by the small white circles. Irregular dose
distributions are seen in the target for Phantoms #3 and #4 even for perfect tracking.
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Figure 4.
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Robustness of target dose coverage to phase delays in tracking shown for the 4 phantoms.
Each box-whisker plot (top left) summarizes the minimum, first quartile, median, third
quartile, and maximum target dose (values are percent of prescribed dose) over all 18
scenarios of motion (with variable period τ and starting phase ϕ) for each value of phase
delay. Dose-volume statistics for each of the 18 individual motion scenarios are shown by
the markers for V95, V107, and D5-D95 for each value of phase delay. Dose and volume
values are reported as percent of prescribed target dose and percent of total target volume,
respectively. Markers are offset slightly (Phantoms #1-#4 presented left to right,
respectively) to ease viewing. For all phantoms, target dose coverage (V95) degrades rapidly
with increasing phase delays in beam tracking.
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Figure 5.

Robustness of target dose coverage to systematic errors in tracking x-, y-, and z-coordinates
shown for the 4 phantoms. Markers are offset slightly (Phantoms #1-#4 presented left to
right, respectively) to ease viewing. A rapid deterioration of target dose coverage (V95) with
increasing offset is seen for Phantom #4 and, to a lesser extent, Phantom #3 even for offsets
as little as 1 mm. Phantoms #1 and #2 showed a greater robustness to systematic errors but
target dose coverage also degraded with shifts greater than 2 mm.
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Figure 6.

Robustness of target dose coverage to to limited acceleration of the range-tracking wedge
shown for the 4 phantoms. Markers are offset slightly (Phantoms #1-#4 presented left to
right, respectively) to ease viewing. Note that Phantom #1 (black markers) did not require
any range tracking, and, therefore, dose coverage does not depend on range-tracking
acceleration. (1 g = 9.81 m/s2)
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Figure 7.
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Perfect beam tracking offsets for Lung Patient #1 for Field #1. Pencil beam x-offsets (green/
light grey), y-offsets (blue/dark grey), and z-offsets (red/medium grey) are shown for each
pencil beam for each motion state. Note the x-offsets of up to approximately 25 mm
correspond directly to SI target motion. z-offsets (i.e., range-offsets) exhibit a more complex
pattern due to motion of the target in heterogeneous tissue. The reference motion state was
5.
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Figure 8.
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Axial view of RBE-weighted dose overlaying CT shown for Lung Patients #1 - #6, indicated
by (a) – (f), respectively, for perfect tracking for a reference case with τ = 4 s and ϕ = 0
degrees. 4D RBE-weighted dose and CT data are shown in the reference motion state at endexhale. The CTV boundary is indicated by the white curve. The prescribed target dose was
32.8 Gy (RBE). This figure gives a view of our treatment plans and shows the variation in
patient anatomy and tumor size for our 6 lung patients.
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Figure 9.

Robustness of target dose coverage to systematic errors in tracking x-, y-, and z-coordinates
shown for Lung Patient #1. A more dramatic decrease in V95 and increase in D5-D95 is seen,
compared to systematic offsets in 1D only (cf. Table 2).
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Figure 10.

Robustness of target dose coverage to limited acceleration (a) of the range-tracking wedge
shown for Lung Patient #1. A moderate drop in target dose coverage V95 is seen for a < 100
g and further worsening is seen for a < 1 g.
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Figure 11.

Robustness of target dose coverage to interfractional motion changes shown for the 6 lung
patients. Markers are offset slightly (Patients #1-#6 presented left to right, respectively) to
ease viewing. All treatment plans were prepared for an initial 4DCT Series #1, and dose was
also calculated using the later 4DCTs. 4DCT Series #2 was acquired for only Patient #1 on
the same day as the initial 4DCT. For all patients, 4DCT Series #3 was acquired 1 week
after the initial 4DCT, and 4DCT Series #4 was acquired 2 weeks after the initial 4DCT.
Target dose coverage V95 deteriorated with time post-planning, dropping approximately 8%
after 1 week.

Author Manuscript
Author Manuscript
Phys Med Biol. Author manuscript; available in PMC 2016 February 21.

Eley et al.

Page 30

Table 1

Author Manuscript

Robustness of target dose coverage <V95> to tracking errors for 4 phantoms. <V95> is the mean V95 for 4
phantoms and 18 motion scenarios. Changes in target coverage (Δ) more than 5% indicated in boldface.
Variable (units)

Magnitude

<V95> (%)

Δ (%)

Perfect Tracking

-

94.8

-

Phase Delay (deg)

5

83.1

−11.7

10

76.4

−18.4

15

72.8

−22.0

0.5

93.9

−0.9

1.0

90.7

−4.1

1.5

86.2

−8.6

0.5

93.9

−0.8

1.0

90.9

−3.9

1.5

86.5

−8.2

0.5

95.2

0.5

1.0

95.6

0.9

1.5

95.7

0.9

0.5

93.3

−1.5

1.0

87.1

−7.6

1.5

80.6

−14.2

1

93.1

−1.6

2

90.8

−3.9

3

88.0

−6.8

4

84.3

−10.4

1

94.7

0.0

2

94.5

−0.2

3

93.4

−1.4

4

90.9

−3.9

1

94.5

−0.3

2

94.0

−0.8

3

93.0

−1.7

4

91.1

−3.7

1

92.7

−2.0

2

88.8

−5.9

3

82.3

−12.5

4

74.3

−20.5

0.001

75.6

−19.2

0.01

81.3

−13.5

0.1

86.0

−8.8

1

93.1

−1.6

8

94.6

−0.2

10

94.6

−0.2

Random X Offset (mm)

Random Y Offset (mm)
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Random Z Offset (mm)

Random XYZ Offset (mm)

Systematic X Offset (mm)

Systematic Y Offset (mm)
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Systematic Z Offset (mm)

Systematic XYZ Offset (mm)

Wedge Acceleration (g)
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Magnitude
100

<V95> (%)

Δ (%)

94.7

0.0
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Robustness of target dose coverage <V95> to tracking errors for Lung Patient #1. <V95> is the mean V95 for
18 motion scenarios. Changes in target coverage (Δ) more than 5% indicated in boldface.
Variable (units)

Magnitude

<V95> (%)

Δ (%)

Perfect Tracking

-

95.5

-

Phase Delay (deg)

5

86.9

−8.7

10

79.2

−16.3

15

77.2

−18.3

0.5

95.5

0.0

1.0

95.6

0.1

1.5

95.4

−0.1

0.5

95.4

−0.1

1.0

95.2

−0.3

1.5

94.9

−0.7

0.5

95.9

0.3

1.0

96.4

0.9

1.5

96.6

1.1

0.5

95.8

0.3

1.0

96.1

0.6

1.5

95.9

0.4

1

95.0

−0.5

2

94.1

−1.4

3

92.5

−3.0

4

90.4

−5.2

1

95.4

−0.1

2

94.9

−0.6

3

93.6

−1.9

4

91.6

−3.9

1

95.6

0.0

2

95.2

−0.3

3

94.5

−1.0

4

93.6

−1.9

1

94.9

−0.6

2

92.7

−2.8

3

87.7

−7.8

4

79.6

−15.9

0.001

79.0

−16.5

0.01

79.7

−15.8

0.1

87.5

−8.0

1

90.3

−5.2

8

90.5

−5.0

10

90.7

−4.8

Random X Offset (mm)

Random Y Offset (mm)

Author Manuscript

Random Z Offset (mm)

Random XYZ Offset (mm)

Systematic X Offset (mm)

Systematic Y Offset (mm)
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Systematic Z Offset (mm)

Systematic XYZ Offset (mm)

Wedge Acceleration (g)
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Magnitude
100

<V95> (%)

Δ (%)

95.2

−0.3
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